Join the club for FREE to access the whole archive and other member benefits.

AgeX Therapeutics

Biotechnology company focused on the development of novel therapeutics for age-related degenerative disease

AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease. AgeX’s mission is to apply the proprietary technology platform related to telomerase-mediated cell immortality and regenerative biology to address a broad range of diseases of aging. The current preclinical development efforts include two cell-based therapies derived from telomerase-positive pluripotent stem cells and two product candidates derived from the company’s proprietary induced Tissue Regeneration (iTR™) technology. AGEX-BAT1 and AGEX-VASC1 are cell-based approaches in the preclinical stage of development comprised of young regenerative cells modified using AgeX’s UniverCyte™ technology facilitating immune tolerance, formulated in HyStem® matrix, designed to correct metabolic imbalances in aging and to restore vascular support in ischemic tissues respectively. AGEX-iTR1547 is a drug-based formulation in preclinical development intended to restore regenerative potential in a wide array of aged tissues afflicted with degenerative disease using the company’s proprietary iTR technology.

Visit website: https://www.agexinc.com/

 AgeXThera

 agextherapeutics

 AgeXThera

 UCs1oGQkvtpbLEiBj6sF7MgA

People at AgeX Therapeutics

Dana Larocca

VP of Discovery Research

Michael D. West

Dr Michael D West is the founder and CEO of AgeX Therapeutics

AgeX Therapeutics News

AgeX credit running out with substantial doubt it can continue

FierceBiotech - 15-Aug-2022

Let's hope their research is either successful for the company or its successors

Read more...

Merger between regeneration companies AgeX and LyGenesis not going ahead

Business Wire - 23-Jul-2021

Both companies to continue with the diverse technologies and product development

Read more...

Orion College ageing research receives 1 million UK pounds from Jim Mellon

Lifespan.io (LEAF) - 18-May-2020

He believes in the importance of boosting immunoresilience among elderly

Read more...

Stem cells from a 110-year-old women open doors to aging research

Phys.org - 20-Mar-2020

Scientists created stem cells from supercentenarian for the first time, calling it "super sauce"

Read more...

Donor supercentenarian’s cells help unlock mysteries of super-longevity

Longevity Technology - 28-Feb-2020

Evidence of cellular age reversal demonstrated in this gateway research

Read more...

Fight Aging! reports back from SENS Research Foundation Pitch Day

Fight Aging! - 20-Jan-2020

When some of these succeed in human trials even more money will pile in to fund further advances

Read more...

Method of Generating Induced Pluripotent Stem Cells

Longevity Technology - 10-Dec-2019

New reprogramming technology could provide an alternate source of material needed for therapies

Read more...

LEAF interviews AgeX Therapeutics CEO Dr. Michael West

Lifespan.io (LEAF) - 30-Sep-2019

May only be a few years away from implementing induced tissue regeneration in humans

Read more...

Michael West examines how to safely revive telomerase

Lifespan.io (LEAF) - 12-Sep-2019

It powers foetal development and telomere length, but also cancers

Read more...

Today's 50 year-olds may live another 100 years

Forbes - 26-Aug-2019

Good summary of some major investments in life extension companies

Read more...

Aubrey de Grey shortens timeframe for human rejuvenation

Next Big Future - 28-Feb-2019

Once proven in mice, demand and funding will surge

Read more...

AgeX Identifies Genes Implicated in Regeneration and Cancer

Business Wire - 02-Jan-2018

Study that reveals genes implicated in tissue regeneration, cancer, and aging. Worked in collabo...

Read more...